Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Lineage Cell Therapeutics, Inc. (BTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2023 |
4
| Hogge Gary S. (SVP,Clinical & Medical Affairs) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.46, valued at
$584k
|
|
| 03/10/2023 |
4
| Samuel George A. III (General Counsel/Secretary) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 650,000 options to buy
@ $1.46, valued at
$949k
|
|
| 03/10/2023 |
4
| Culley Brian M (President and CEO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 1,900,000 options to buy
@ $1.46, valued at
$2.8M
|
|
| 03/10/2023 |
4
| Howe Jill Ann (CFO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.46, valued at
$219k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Russell Angus C. (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 07/06/2022 |
4
| ANDREWS DEBORAH J (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 07/06/2022 |
4
| Jayasuriya Anula (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 07/06/2022 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| BAILEY DON M (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 07/06/2022 |
4
| BRADSHER NEAL C (10% Owner) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Culley Brian M (President and CEO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,343 shares
@ $1.58, valued at
$8.4k
Exercised 15,450 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Culley Brian M (President and CEO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,343 shares
@ $1.54, valued at
$8.2k
Bought 6,400 shares
@ $1.53, valued at
$9.8k
Exercised 15,450 restricted stock units
@ $0 |
|
| 03/29/2022 |
4
| Amin Dipti (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 35,000 shares
@ $1.63, valued at
$57.1k
|
|
| 03/28/2022 |
4
| Culley Brian M (President and CEO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 5,250 shares
@ $1.38, valued at
$7.2k
|
|
| 03/25/2022 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 260,106 shares
@ $1.366, valued at
$355.3k
Bought 200,000 shares
@ $1.4217, valued at
$284.3k
Bought 470,000 shares
@ $1.4426, valued at
$678k
|
|
| 03/25/2022 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 7,000 shares
@ $1.4, valued at
$9.8k
|
|
| 03/11/2022 |
4
| Culley Brian M (President and CEO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 1,250,000 options to buy
@ $1.4, valued at
$1.8M
Granted 300,000 restricted stock units
@ $0 |
|
| 03/11/2022 |
4
| Samuel George A. III (General Counsel/Secretary) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 650,000 options to buy
@ $1.4, valued at
$910k
|
|
| 03/11/2022 |
4
| Hogge Gary S. (SVP,Clinical & Medical Affairs) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 450,000 options to buy
@ $1.4, valued at
$630k
|
|
| 03/11/2022 |
4
| Cook Kevin Leon (CFO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 650,000 options to buy
@ $1.4, valued at
$910k
|
|
| 02/15/2022 |
4
| Samuel George A. III (General Counsel/Secretary) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 24,303 restricted stock units
@ $0 |
|
| 02/15/2022 |
4
| Hogge Gary S. (SVP,Clinical & Medical Affairs) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 52,081 restricted stock units
@ $0 |
|
| 02/15/2022 |
4
| Cook Kevin Leon (CFO) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 13,888 restricted stock units
@ $0 |
|
|
|
|